Business Description
Enovis Corp
NAICS : 333249
SIC : 3561
ISIN : US1940141062
Description
Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy.. The company conducts its operations through two operating segments: Prevention & Recovery ("P&R") and Reconstructive ("Recon"). It generates majority revenue form Prevention & Recovery segment.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.06 | |||||
| Equity-to-Asset | 0.8 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | 1.53 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.86 | |||||
| Beneish M-Score | -2.93 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -26.6 | |||||
| 3-Year EBITDA Growth Rate | -20.5 | |||||
| 3-Year Book Growth Rate | -10.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 7.5 | |||||
| Future 3-5Y Total Revenue Growth Rate | 6.73 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 73.66 | |||||
| 9-Day RSI | 60.69 | |||||
| 14-Day RSI | 55.57 | |||||
| 6-1 Month Momentum % | 1.04 | |||||
| 12-1 Month Momentum % | -13.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.38 | |||||
| Quick Ratio | 1.13 | |||||
| Cash Ratio | 0.06 | |||||
| Days Inventory | 266.29 | |||||
| Days Sales Outstanding | 78.74 | |||||
| Days Payable | 122.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11.3 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 56.38 | |||||
| Operating Margin % | -5.32 | |||||
| Net Margin % | -3.24 | |||||
| ROE % | -1.41 | |||||
| ROA % | -0.99 | |||||
| ROIC % | 7.5 | |||||
| ROC (Joel Greenblatt) % | 3.31 | |||||
| ROCE % | 0.64 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 25.32 | |||||
| Shiller PE Ratio | 25.09 | |||||
| PS Ratio | 1.92 | |||||
| PB Ratio | 0.89 | |||||
| Price-to-Tangible-Book | 8.19 | |||||
| EV-to-EBIT | 120.14 | |||||
| EV-to-Forward-EBIT | 4.97 | |||||
| EV-to-EBITDA | 14.53 | |||||
| EV-to-Forward-EBITDA | 4.26 | |||||
| EV-to-Revenue | 2.13 | |||||
| EV-to-Forward-Revenue | 2.02 | |||||
| EV-to-FCF | -23.32 | |||||
| Price-to-Projected-FCF | 0.84 | |||||
| Price-to-Median-PS-Value | 2.19 | |||||
| Earnings Yield (Greenblatt) % | 0.83 | |||||
| Forward Rate of Return (Yacktman) % | -6.84 |
Balance Sheet Breakdown
Cashflow Statement Breakdown
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:ENOV
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Enovis Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,593.795 | ||
| EPS (TTM) ($) | -0.96 | ||
| Beta | 1.55 | ||
| Volatility % | 39.15 | ||
| 14-Day RSI | 55.57 | ||
| 14-Day ATR ($) | 1.314195 | ||
| 20-Day SMA ($) | 55.0915 | ||
| 12-1 Month Momentum % | -13.93 | ||
| 52-Week Range ($) | 43.88 - 68.15 | ||
| Shares Outstanding (Mil) | 54.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Enovis Corp Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Enovis Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Enovis Corp Frequently Asked Questions
What is Enovis Corp(ENOV)'s stock price today?
The current price of ENOV is $56.24. The 52 week high of ENOV is $68.15 and 52 week low is $43.88.
When is next earnings date of Enovis Corp(ENOV)?
The next earnings date of Enovis Corp(ENOV) is 2023-08-04 Est..
Does Enovis Corp(ENOV) pay dividends? If so, how much?
Enovis Corp(ENOV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers